| James Higgins, PHARMACIST | |
|
676 Southbridge St, Auburn, MA 01501-1801 | |
| (508) 832-6257 | |
| Not Available |
| Full Name | James Higgins |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 676 Southbridge St, Auburn, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891399028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20785 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Higgins, PHARMACIST 676 Southbridge St, Auburn, MA 01501-1801 Ph: (508) 832-6257 | James Higgins, PHARMACIST 676 Southbridge St, Auburn, MA 01501-1801 Ph: (508) 832-6257 |
News Archive
Few things are more stressful than dealing with a sick child. From discussing treatment with a pediatrician to complying with day care policies, a parent must consider many factors when making a decision about their child's health. Now, a recent study from the University of Missouri and the University of Michigan is shedding light on the significant divide that can exist between patients and physicians about the same terminology-especially when it comes to discussing "pink eye," a particular flashpoint in childcare.
Chronically ill children with private insurance are much less likely than those with public insurance, such as Medi-Cal, to be admitted to a California hospital offering specialized pediatric care, according to a new study by researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.
Many cancer researchers believe that cutting-edge advances in genomics will pave the way for personalized or "precision" cancer medicine for all patients in the near future. A new study by researchers at Dana-Farber Cancer Institute, however, suggest that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients' tumor samples, while others plan to offer this type of cancer gene testing to most of their patients.
Memorial Sloan-Kettering Cancer Center (MSKCC) researchers have found that melanoma patients with a family history of melanoma and/or dysplastic nevi (abnormal moles) are at high risk of developing multiple primary melanomas (MPM). Researchers recommend more intensive follow up for these high-risk patients.
› Verified 7 days ago
Ina Beqo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 676 Southbridge St, Auburn, MA 01501 Phone: 508-832-6257 | |
Anna S Smreczak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 Simonds St, Auburn, MA 01501 Phone: 508-832-3996 | |
Vjollca Aliu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 676 Southbridge St, Auburn, MA 01501 Phone: 088-326-2575 | |
Emmanuel Armanious, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 676 Southbridge St, Auburn, MA 01501 Phone: 508-832-6257 |